Literature DB >> 28281034

Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice.

Itefaq Hussain Qureshi1, Azra Riaz1, Rafeeq Alam Khan2, Afaq Ahmed Siddiqui3.   

Abstract

Status epilepticus is a life threatening neurological medical emergency. It may cause serious damage to the brain and even death in many cases if not treated properly. There is limited choice of drugs for the short term and long term management of status epilepticus and the dugs recommended for status epilepticus possess various side effects. The present study was designed to investigate synergistic anticonvulsant effects of pregabalin with amlodipine on acute seizure model of epilepsy in mice. Pentylenetetrazole was used to induce acute seizures which mimic status epilepticus. Pregabalin and amlodipine were used in combination to evaluate synergistic anti-seizure effects on acute seizure model of epilepsy in mice. Diazepam and valproate were used as reference dugs. The acute anti-convulsive activity of pregabalin with amlodipine was evaluated in vivo by the chemical induced seizures and their anti-seizure effects were compared with pentylenetetrazole, reference drugs and to their individual effects. The anti-seizure effects of tested drugs were recorded in seconds on seizure characteristics such as latency of onset of threshold seizures, rearing and fallings and Hind limbs tonic extensions. The seizure protection and mortality to the animals exhibited by the drugs were recorded in percentage. Combination regimen of pregabalin with amlodipine exhibited dose dependent significant synergistic anticonvulsant effects on acute seizures which were superior to their individual effects and equivalent to reference drugs.

Entities:  

Keywords:  Amlodipine; Antiepileptic drugs; Diazepam; Pentylenetetrazole; Pregabalin; Valproate

Mesh:

Substances:

Year:  2017        PMID: 28281034     DOI: 10.1007/s11011-017-9979-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  50 in total

Review 1.  New horizons in the development of antiepileptic drugs.

Authors:  Wolfgang Löscher; Dieter Schmidt
Journal:  Epilepsy Res       Date:  2002-06       Impact factor: 3.045

Review 2.  Regulation of neuronal T-type calcium channels.

Authors:  Mircea C Iftinca; Gerald W Zamponi
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

Review 3.  Mechanisms of action of antiepileptic drugs: the search for synergy.

Authors:  Carl E Stafstrom
Journal:  Curr Opin Neurol       Date:  2010-04       Impact factor: 5.710

4.  Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures.

Authors:  R M Kamiński; M Mazurek; W A Turski; Z Kleinrok; S J Czuczwar
Journal:  Pharmacol Biochem Behav       Date:  2001-04       Impact factor: 3.533

5.  Anticonvulsant effects of dihydropyridine Ca2+ antagonists in electrocortical shock seizures.

Authors:  F B Meyer; R E Anderson; T M Sundt
Journal:  Epilepsia       Date:  1990 Jan-Feb       Impact factor: 5.864

Review 6.  Some common issues in the use of antiepileptic drugs.

Authors:  Jorge J Asconapé
Journal:  Semin Neurol       Date:  2002-03       Impact factor: 3.420

7.  Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.

Authors:  P Zapater; J Javaloy; J F Román; M T Vidal; J F Horga
Journal:  Brain Res       Date:  1998-06-15       Impact factor: 3.252

8.  Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model.

Authors:  Jarogniew J Luszczki; Michał K Trojnar; Marcin P Trojnar; Zaneta Kimber-Trojnar; Beata Szostakiewicz; Anna Zadrozniak; Kinga K Borowicz; Stanisław J Czuczwar
Journal:  Pharmacol Rep       Date:  2007 Nov-Dec       Impact factor: 3.024

9.  Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-19       Impact factor: 3.000

10.  Pregabalin for the management of partial epilepsy.

Authors:  Philippe Ryvlin; Emilio Perucca; Sylvain Rheims
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more
  1 in total

1.  Pregabalin mitigates microglial activation and neuronal injury by inhibiting HMGB1 signaling pathway in radiation-induced brain injury.

Authors:  Zhan Zhang; Jingru Jiang; Yong He; Jinhua Cai; Jiatian Xie; Minyi Wu; Mengdan Xing; Zhenzhen Zhang; Haocai Chang; Pei Yu; Siqi Chen; Yuhua Yang; Zhongshan Shi; Qiang Liu; Haohui Sun; Baixuan He; Junbo Zeng; Jialin Huang; Jiongxue Chen; Honghong Li; Yi Li; Wei-Jye Lin; Yamei Tang
Journal:  J Neuroinflammation       Date:  2022-09-21       Impact factor: 9.587

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.